Coadministration of fluconazole to boost subtherapeutic sirolimus concentrations: a case report

Individual sirolimus whole blood concentrations are highly variable, critically influenced by the concomitant use of cytochrome P450 (CYP) 3A inducers or inhibitors, and also modulated by food. Therapeutic drug monitoring is therefore recommended, especially at treatment start or in circumstances th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Scherkl, Camilo (VerfasserIn) , Meid, Andreas (VerfasserIn) , Cuntz, Sven Enrico (VerfasserIn) , Claßen, Laura (VerfasserIn) , Weiß, Johanna (VerfasserIn) , Czock, David (VerfasserIn) , Haefeli, Walter E. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: June 2024
In: Pharmacology research & perspectives
Year: 2024, Jahrgang: 12, Heft: 3, Pages: 1-6
ISSN:2052-1707
DOI:10.1002/prp2.1198
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1002/prp2.1198
Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/prp2.1198
Volltext
Verfasserangaben:Camilo Scherkl, Andreas D. Meid, Sven E. Cuntz, Laura Classen, Johanna Weiss, David Czock, Walter E. Haefeli

MARC

LEADER 00000caa a2200000 c 4500
001 1893074471
003 DE-627
005 20241205145728.0
007 cr uuu---uuuuu
008 240702s2024 xx |||||o 00| ||eng c
024 7 |a 10.1002/prp2.1198  |2 doi 
035 |a (DE-627)1893074471 
035 |a (DE-599)KXP1893074471 
035 |a (OCoLC)1475301188 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Scherkl, Camilo  |e VerfasserIn  |0 (DE-588)1334631719  |0 (DE-627)1893081311  |4 aut 
245 1 0 |a Coadministration of fluconazole to boost subtherapeutic sirolimus concentrations  |b a case report  |c Camilo Scherkl, Andreas D. Meid, Sven E. Cuntz, Laura Classen, Johanna Weiss, David Czock, Walter E. Haefeli 
264 1 |c June 2024 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht: 18. April 2024 
500 |a Gesehen am 02.07.2024 
520 |a Individual sirolimus whole blood concentrations are highly variable, critically influenced by the concomitant use of cytochrome P450 (CYP) 3A inducers or inhibitors, and also modulated by food. Therapeutic drug monitoring is therefore recommended, especially at treatment start or in circumstances that can influence sirolimus exposure. In this case report, we highlight the challenge of achieving therapeutic sirolimus concentrations and present pragmatic solutions with regimen adaptions, pharmacokinetic enhancement (use of a drug-drug interaction), concentration monitoring, and subsequent modeling of population pharmacokinetics to support treatment decisions. In a 69-year-old female patient with allogeneic hematopoietic stem cell transplantation, sirolimus concentrations were stable until she developed cerebral toxoplasmosis with tonic-clonic seizures. During treatment of this acute infection, sirolimus concentrations dropped to subtherapeutic levels and remained largely unaffected by dose increases. [Correction added on 4 May 2024, after first online publication: The word “tacrolimus concentrations” has been changed to “sirolimus concentrations” in the preceding sentence.] Only the simultaneous administration of the CYP3A4 inhibitor fluconazole and a shortening of the sirolimus dosing intervals to a (non-approved) twice-daily administration led to successful control of the concentrations, which ultimately even made a dose reduction possible. This intervention resulted in an increase of sirolimus mean trough concentration to 5.85 ng/mL, i.e., into the desired target range. Additionally, a higher ratio of sirolimus trough levels/daily dose from 26.9 to 109 ng/mL/mg/kg/day was achieved with the initiation of fluconazole. Thus, this case report describes the use of clinical pharmacological concepts and pharmacokinetic modeling to optimize treatment strategies in an individual patient. This strategy could be generalized to other CYP inhibitors and other treatment regimens. 
650 4 |a cytochrome P-450 enzyme inhibitors 
650 4 |a fluconazole 
650 4 |a pharmacokinetics 
650 4 |a sirolimus 
700 1 |a Meid, Andreas  |d 1981-  |e VerfasserIn  |0 (DE-588)1076301991  |0 (DE-627)834660377  |0 (DE-576)445184582  |4 aut 
700 1 |a Cuntz, Sven Enrico  |d 1993-  |e VerfasserIn  |0 (DE-588)1299857914  |0 (DE-627)1857238788  |4 aut 
700 1 |a Claßen, Laura  |d 1988-  |e VerfasserIn  |0 (DE-588)1162157798  |0 (DE-627)1025599926  |0 (DE-576)507228413  |4 aut 
700 1 |a Weiß, Johanna  |e VerfasserIn  |0 (DE-588)1050230906  |0 (DE-627)783666322  |0 (DE-576)404441114  |4 aut 
700 1 |a Czock, David  |e VerfasserIn  |0 (DE-588)120971011  |0 (DE-627)705128253  |0 (DE-576)180276719  |4 aut 
700 1 |a Haefeli, Walter E.  |d 1958-  |e VerfasserIn  |0 (DE-588)124572359  |0 (DE-627)656806141  |0 (DE-576)340514221  |4 aut 
773 0 8 |i Enthalten in  |t Pharmacology research & perspectives  |d Chichester [u.a.] : Wiley, 2013  |g 12(2024), 3 vom: Juni, Artikel-ID e1198, Seite 1-6  |h Online-Ressource  |w (DE-627)771394683  |w (DE-600)2740389-0  |w (DE-576)39669604X  |x 2052-1707  |7 nnas  |a Coadministration of fluconazole to boost subtherapeutic sirolimus concentrations a case report 
773 1 8 |g volume:12  |g year:2024  |g number:3  |g month:06  |g elocationid:e1198  |g pages:1-6  |g extent:6  |a Coadministration of fluconazole to boost subtherapeutic sirolimus concentrations a case report 
856 4 0 |u https://doi.org/10.1002/prp2.1198  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/prp2.1198  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20240702 
993 |a Article 
994 |a 2024 
998 |g 124572359  |a Haefeli, Walter E.  |m 124572359:Haefeli, Walter E.  |d 910000  |d 910100  |e 910000PH124572359  |e 910100PH124572359  |k 0/910000/  |k 1/910000/910100/  |p 7  |y j 
998 |g 120971011  |a Czock, David  |m 120971011:Czock, David  |d 910000  |d 910100  |d 50000  |e 910000PC120971011  |e 910100PC120971011  |e 50000PC120971011  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 6 
998 |g 1050230906  |a Weiß, Johanna  |m 1050230906:Weiß, Johanna  |d 910000  |d 910100  |d 50000  |e 910000PW1050230906  |e 910100PW1050230906  |e 50000PW1050230906  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 5 
998 |g 1162157798  |a Claßen, Laura  |m 1162157798:Claßen, Laura  |d 910000  |d 910100  |e 910000PC1162157798  |e 910100PC1162157798  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 1299857914  |a Cuntz, Sven Enrico  |m 1299857914:Cuntz, Sven Enrico  |d 910000  |d 910100  |e 910000PC1299857914  |e 910100PC1299857914  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1076301991  |a Meid, Andreas  |m 1076301991:Meid, Andreas  |d 910000  |d 910100  |e 910000PM1076301991  |e 910100PM1076301991  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1334631719  |a Scherkl, Camilo  |m 1334631719:Scherkl, Camilo  |d 910000  |d 910100  |e 910000PS1334631719  |e 910100PS1334631719  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1893074471  |e 4544833140 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1893074471"],"doi":["10.1002/prp2.1198"]},"title":[{"title_sort":"Coadministration of fluconazole to boost subtherapeutic sirolimus concentrations","title":"Coadministration of fluconazole to boost subtherapeutic sirolimus concentrations","subtitle":"a case report"}],"recId":"1893074471","note":["Online veröffentlicht: 18. April 2024","Gesehen am 02.07.2024"],"person":[{"roleDisplay":"VerfasserIn","family":"Scherkl","given":"Camilo","display":"Scherkl, Camilo","role":"aut"},{"given":"Andreas","role":"aut","display":"Meid, Andreas","family":"Meid","roleDisplay":"VerfasserIn"},{"family":"Cuntz","roleDisplay":"VerfasserIn","given":"Sven Enrico","display":"Cuntz, Sven Enrico","role":"aut"},{"given":"Laura","role":"aut","display":"Claßen, Laura","roleDisplay":"VerfasserIn","family":"Claßen"},{"family":"Weiß","roleDisplay":"VerfasserIn","role":"aut","display":"Weiß, Johanna","given":"Johanna"},{"roleDisplay":"VerfasserIn","family":"Czock","given":"David","role":"aut","display":"Czock, David"},{"family":"Haefeli","roleDisplay":"VerfasserIn","given":"Walter E.","role":"aut","display":"Haefeli, Walter E."}],"name":{"displayForm":["Camilo Scherkl, Andreas D. Meid, Sven E. Cuntz, Laura Classen, Johanna Weiss, David Czock, Walter E. Haefeli"]},"physDesc":[{"extent":"6 S."}],"relHost":[{"recId":"771394683","titleAlt":[{"title":"Pharmacology research and perspectives"},{"title":"PRP"}],"pubHistory":["1.2013 -"],"note":["Gesehen am 11.08.20"],"disp":"Coadministration of fluconazole to boost subtherapeutic sirolimus concentrations a case reportPharmacology research & perspectives","id":{"issn":["2052-1707"],"zdb":["2740389-0"],"eki":["771394683"]},"title":[{"title":"Pharmacology research & perspectives","title_sort":"Pharmacology research & perspectives","subtitle":"PRP"}],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisher":"Wiley","dateIssuedDisp":"2013-","dateIssuedKey":"2013","publisherPlace":"Chichester [u.a.]"}],"part":{"pages":"1-6","year":"2024","extent":"6","issue":"3","volume":"12","text":"12(2024), 3 vom: Juni, Artikel-ID e1198, Seite 1-6"},"physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["British Pharmacological Society ; American Society for Pharmacology and Experimental Therapeutics"]}}],"language":["eng"],"origin":[{"dateIssuedDisp":"June 2024","dateIssuedKey":"2024"}],"type":{"bibl":"article-journal","media":"Online-Ressource"}} 
SRT |a SCHERKLCAMCOADMINIST2024